Franklin, J. M., Platt, R., Dreyer, N. A., London, A. J., Simon, G. E., Watanabe, J. H., . . . Califf, R. M. (2022). When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments? Clinical pharmacology and therapeutics, 111(1), 108-115. https://doi.org/10.1002/cpt.2255
Citace podle Chicago (17th ed.)Franklin, Jessica M., Richard Platt, Nancy A. Dreyer, Alex John London, Gregory E. Simon, Jonathan H. Watanabe, Michael Horberg, Adrian Hernandez, a Robert M. Califf. "When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?" Clinical Pharmacology and Therapeutics 111, no. 1 (2022): 108-115. https://doi.org/10.1002/cpt.2255.
Citace podle MLA (9th ed.)Franklin, Jessica M., et al. "When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?" Clinical Pharmacology and Therapeutics, vol. 111, no. 1, 2022, pp. 108-115, https://doi.org/10.1002/cpt.2255.